Anti-pathogen device
Abstract
An anti-pathogen device may be useful as a wound dressing, an antibiotic sock, a mastitis cup, a tampon, or a window, door or bed cover. It comprises a carrier and a pathogen-binding component and a binding intermediate is attached to the carrier to facilitate binding of the pathogen-binding component to the carrier by forming a pathogen-binding construct with the pathogen-binding component. The pathogen binding construct may be lactoferrin, hololactoferrin, apolactoferrin, or asialolactoferrin. A carbohydrate binder binds the pathogen binding construct to the carrier. A device for protection against pathogens such as viruses. The device could be a wearable device such as a facemask. The device comprises a carrier comprising a textile material (e.g. cotton or synthetics). The device further comprises a glycoprotein (e.g. as a coating on or embedded in the carrier). Examples of glycoproteins that could be used include albumin, lactoferrin, casein, or lactoglobulin. The carrier is permeable to airflow.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. An anti-pathogen device comprising:
a carrier comprising a textile made of cotton or a cotton mix comprising polyester material;
silver particles impregnated in the carrier as an antimicrobial;
a glycoprotein comprising sialic acid, the glycoprotein selected from a fetuin protein, an albumin protein, a lactoferrin protein, a casein protein, a lactoglobulin protein, or glycomacropeptide (GMP);
a reactive organic-inorganic sol binder that is attached to both the glycoprotein and the carrier;
wherein the glycoprotein is coupled to the carrier via attachment with the reactive organic-inorganic sol binder carrier is permeable to airflow.
2. The anti-pathogen device of claim 1 , wherein the glycoprotein is a fetuin protein.
3. The anti-pathogen device of claim 2 , wherein the fetuin protein is fetuin or asialofetuin.
4. The anti-pathogen device of claim 1 , wherein the glycoprotein is an albumin protein.
5. The anti-pathogen device of claim 4 , wherein the albumin protein is albumin or α-lactalbumin.
6. The anti-pathogen device of claim 1 , wherein the glycoprotein is an a lactoferrin protein.
7. The anti-pathogen device of claim 6 , wherein the lactoferrin protein is lactoferrin, hololactoferrin, apolactoferrin, or asialolactoferrin.
8. The anti-pathogen device of claim 1 , wherein the glycoprotein is a casein protein.
9. The anti-pathogen device of claim 8 , wherein the casein protein is α-casein, β-casein, or κ-casein.
10. The anti-pathogen device of claim 1 , wherein the glycoprotein is a lactoglobulin protein.
11. The anti-pathogen device of claim 10 , wherein the lactoglobulin protein is β-lactoglobulin.
12. The anti-pathogen device of claim 1 17, wherein the reactive organic-inorganic sol binder is made using a nanotechnology sol gel process.
13. The anti-pathogen device of claim 1 , wherein the device is a face mask.
14. The anti-pathogen device of claim 1 17, wherein the carrier is impregnated with the reactive organic-inorganic sol binder.
15. The anti-pathogen device of claim 1 , wherein the device is a filter used in an air conditioning unit.
16. The anti-pathogen device of claim 1 , wherein the device is a filter used in a blood filtration device.
17. The anti-pathogen device of claim 1, further comprising a reactive organic-inorganic sol binder that is attached to both the glycoprotein and the carrier.
18. The anti-pathogen device of claim 17, further comprising silver particles impregnated in the carrier as an antimicrobial.Join the waitlist — get patent alerts
Track USRE49959E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.